TSTickerStarGet alerts

Basel Medical Group Ltd prices $7.98M registered direct offering of units

On October 7, 2026, Basel Medical Group Ltd (Nasdaq: BMGL) entered into a placement agency agreement with Cathay Securities, Inc. and a securities purchase agreement with certain purchasers to issue and sell 6,000,000 units at $1.33 per unit in a registered direct offering, for total gross proceeds of US$7.98 million and estimated net proceeds of approximately US$7.28 million. Each unit consists of one ordinary share (or one Pre-Funded Warrant in lieu thereof) and one Common Warrant exercisable at 110% of the un...

Share this story

Key takeaways

  • Deal size: 6,000,000 units at US$1.33 per unit, for US$7.98 million gross and approximately US$7.28 million net proceeds.

  • Unit structure: each unit comprises one Ordinary Share (or one Pre-Funded Warrant exercisable at US$0.01) plus one Common Warrant exercisable at US$1.463 (110% of unit price) with a five-year term and a zero-cash exercise option.

  • Share-count impact: outstanding Ordinary Shares rise from 1,582,111 pre-offering to 7,582,111 immediately upon closing, with 6,000,000 Common Warrants also outstanding.

  • Use of proceeds: general working capital, potential mergers and acquisitions, and other general corporate purposes.

  • Placement agent economics: Cathay Securities, Inc. is the exclusive placement agent, receiving a 6.0% cash fee on gross proceeds and expense reimbursement capped at US$60,000 (with a US$20,000 advance).

  • Lock-up and restrictions: 180-day lock-up applies to the Company, its executive officers, directors, and certain 5%+ shareholders, including a prohibition on additional Variable Rate Transactions without placement-agent consent.

  • Registration and timing: offered under effective Form F-1 (File No. 333-298988); placement agency and securities purchase agreements signed October 7, 2026, with closing via Delivery Versus Payment.

Key metrics

Units offeredOctober 2026 offering
6,000,000
Unit offering priceOctober 2026 offering
US$1.33
Gross proceedsOctober 2026 offering
US$7.98 million
Net proceeds (estimated)October 2026 offering
US$7.28 million
Common Warrant exercise price5-year term from issuance
US$1.463
Pre-Funded Warrant exercise priceImmediately exercisable until exercised in full
US$0.01
Common Warrants outstanding (post-closing)Upon closing
6,000,000
Pre-offering Ordinary Shares outstandingImmediately prior to offering
1,582,111

Primary source

TickerStar generated this brief from an official company, investor-relations, earnings-call, or regulatory source. Review the primary material before making an investment decision.

Open SEC filing

Follow BMGL in real time

Get material earnings, filing, IR, and earnings-call alerts by email.

Create a free alert